Universidad Europea de Madrid
Madrid, Spain
NCT Number: NCT05127928
Determine if acute supplementation with antioxidant vitamins (vitamin C and vitamin E) influences the muscle damage and fatigue caused after an acute session of eccentric training.
Looking for future studies?
Notify Me18 year–33 year
All sexes
Interventional
Not applicable
Madrid, Spain
A randomized, single-blind, placebo-control parallel trial will be conducted. In a previous session volunteers will be interviewed to determine if they meet the inclusion criteria.
Participants should avoid ingesting of foods that contain high amounts of antioxidant compounds: more than two juices of fruits, more than four cups of coffee or tea. Juices with high antioxidant content should be avoided. Alcoholic beverages should also be avoided. Participants will be divided in to groups and will performance one resistance exercise sessions. Prior to exercise, one group will intake supplementation VitC (1000 mg) + VitE (235 mg) and the other supplementation with placebo.
The following sequence will be performed in each session: 1) baseline assessment (analysis of the composition body, blood draw and parameters of performance) prior to exercise session ; 2) administration of vitamin or placebo supplementation 2 hours before exercise session ; 3) post-exercise assessments (blood biomarkers and performance parameters) immediately after the session and after 24 hours. DOMS will also be assessed 48 h and 72 h after training. The training session implemented will be designed by a Sport Scientific
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Antioxidant supplementation
Other names: Ascorbic acid and tocopherol
Placebo administration
Time frame: Prior to the intervention
Determination of body composition using skinfolds measurements
Time frame: 0 hours post exercise
Delayed onset muscle soreness. This outcome will be measure with a 10-point visual analogic scale (0= no pain; 10 = worst possible pain)
Time frame: 24 hours post exercise
Delayed onset muscle soreness. This outcome will be measure with a 10-point visual analogic scale (0= no pain; 10 = worst possible pain)
Time frame: 2 hours prior to exercise
MDA will be analyzed from a blood sample
Time frame: 2 hours prior to exercise
CK will be analyzed from a blood sample
Time frame: Inmediatly after exercise
MDA will be analyzed from a blood sample
Time frame: 24 hours after exercise
MDA will be analyzed from a blood sample
Time frame: 24 hours after exercise
CK will be analyzed from a blood sample
Time frame: 2 hours prior to exercise
Jump height (cm) in a counter movement jump measured with Octojump Platform
Time frame: Inmediatly after exercise
Jump height (cm) in a counter movement jump measured with Octojump Platform
Time frame: 24 h after exercise
Jump height (cm) in a counter movement jump measured with Octojump Platform
Time frame: 24 h after exercise
Jump Height (cm) in a Squat Jump measured with Octojump Platform
Time frame: Inmediately after exercise
Jump Height (cm) in a Squat Jump measured with Octojump Platform
Time frame: 2 hours prior to exercise
Jump height (cm) in a squat jump with Octojump Platform measured with Octojump Platform
Time frame: 2 hours prior to exercise
Jump height (cm) was measured in different drop jumps with Octojump Platform
Time frame: Inmediately after exercise
Jump height (cm) was measured in different drop jumps with Octojump Platform
Time frame: Inmediately after exercise
Contact time (s)measured in different drop jumps with Octojump Platform
Time frame: Inmediately after exercise
Jump height (cm) measured in different drop jumps with Octojump Platform
Time frame: 24 hours after exercise
Contact time (s) measured in different drop jumps with Octojump Platform
Time frame: 24 hours after exercise
Jump height (cm) measured in different drop jumps with Octojump Platform
Time frame: Inmediately after exercise
Capillary blood lactate evaluated with Lactate Pro 2
Time frame: 2 hours before exercise
Capillary blood lactate with Lactate Pro 2
Universidad Europea de Madrid
Other
Acronym: Antioxidant
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06993740
Anesthesia, Cardiovascular Diseases
Jakarta, DKI Jakarta, Indonesia
View Trial DetailsNCT07728422
Muscle Damage, Oxidative Stress
Malatya, Turkey (Türkiye)
View Trial DetailsNCT07726979
Athletic Performance, Bone Metabolism
Surabaya, Jawa Timur - East Java, Indonesia
View Trial DetailsNCT07703215
Antioxidant Capacity, Atopic Dermatitis
Cheras, Kuala Lumpur, Malaysia
View Trial Details